Voltar à classificação

CorVel Corp. (CRVL)

NEUTRAL
Financial ServicesInsurance BrokersUnited States

Fundamental

66

Preço

$69.93

Capitalização de Mercado

$3.61B

Parte 1 · Quanto vale a empresa

Visão Geral

CorVel Corporation provides workers' compensation, general and auto liability, and hospital bill auditing and payment integrity solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing; preferred provider management and reimbursement; retrospective utilization, facility claim, and professional review; pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions. In addition, it provides a range of patient management services, such as claims management customers, case management, 24/7 nurse triage, utilization management, vocational rehabilitation, and life care planning, as well as processing of claims for self-insured payors with respect to property and casualty insurance. The company offers solutions to employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. CorVel Corporation was incorporated in 1987 and is based in Fort Worth, Texas.

No editorial profile for this company yet

Direct competitors

Who this company fights with for the same customers

No editorial profile for this company yet

No competitor list for this company yet.

Balanço & Liquidez

Receita

$984M

Últimos 12 meses (até 30/06/2026)

Resultado Líquido

$115M

Últimos 12 meses (até 30/06/2026)

Fluxo de Caixa Livre

$110M

Capital Próprio Total

$394M

Passivo Total

$249M

Rácio de Liquidez

1.94

Cobertura de Juros

-

Dívida/EBITDA

0.15

Resultados Por Ação

Receita & Resultado Líquido

Fluxo de Caixa Livre

Decomposição dos Resultados

Demonstração histórica

Margens ao longo do tempo

A dívida ao longo do tempo

Quanto pesa a dívida

Grelha do crescimento

Crescimento — Receitas

Estimativa de Valor Justo

General caseSobrevalorizada

Valor Justo

$26.35

Preço Atual

$69.93

Margem de Segurança

-165.4%

Intervalo de Valor Justo

$21.89 - $30.80

Métodos de Estimativa

Analyst price target:Not enough data to compute it
Discounted cash flow (DCF):$27.68
Earnings multiple (P/E):$29.87
Graham growth formula:$16.83
Earnings power value (EPV):$21.27
Justified P/B:$27.00
Dividend discount (Gordon):Not enough data to compute it
P/FFO, funds from operations:Not enough data to compute it
Mid-cycle earnings:Not enough data to compute it
Revenue multiple:Not enough data to compute it

Métricas de Avaliação

Rácio P/E

31.66

ROE

28.0%

Rácio P/B

8.80

P/FCF

31.61

Margem Bruta

24.8%

ROIC

-

Radar de Rentabilidade

Value Creation (Economic Moat)

ROIC

-

WACC

10.3%

ROIC − WACC

-

Critérios de Análise Fundamental

Aprovado (14)

  • EPS shows upward trend
  • Price CAGR 19.12%
  • Debt/Equity ratio
  • Positive Free Cash Flow
  • Current Ratio
  • Debt/EBITDA
  • Return on Tangible Assets
  • Low reliance on intangibles
  • ROE 29.9%
  • Revenue Growth 5Y 11.6%
  • Earnings Quality (OCF/NI) 1.31
  • Share Dilution -0.8%
  • Net Margin Trend 11.7% vs 11.0%
  • Piotroski F-Score 7/9

Reprovado (7)

  • EPS CAGR 0.24%
  • Gross Margin 24.8%
  • P/FCF 31.61
  • P/B Ratio 8.80
  • CapEx intensity
  • Price below Graham Number
  • DCF valuation (Overvalued)

Indisponível (7)

  • ROIC NaN%
  • Dividend Payout NaN%
  • Operating Margin NaN%
  • Interest Coverage
  • Analyst Consensus (Finnhub)
  • Earnings Surprise (no valid data)
  • PEG Ratio (need PE > 0 and growth > 0)

Piotroski F-Score

7/9

Saúde financeira sólida

score
criteria

Qualidade dos Resultados

1.31

Alta qualidade: resultados respaldados por caixa

Diluição de Ações

-0.8%

A recomprar ações. Favorável ao acionista

Governação

Equipa Executiva

NomeCargoIdade
Mr. Michael G. CombsExecutive Chair61
Mr. Brian S. NicholsChief Financial Officer44
Ms. Jennifer L. YossVice President of Accounting47
Mr. Maxim ShishinChief Information Officer50
Mr. Mark E. BertelsExecutive Vice President of Risk Management Services62
Ms. Sarah ScottPresident & CEO48
Ms. Sharon F. O'ConnorVice President of Legal Services-
Melissa StoranVice President of Marketing-
Jason WheelerVice President of Sales & Account Management-
Mr. Jeffrey D. GurtcheffChief Claims Officer-

Risco de Auditoria

4

Risco do Conselho

6

Risco de Remuneração

5

Risco dos Direitos dos Acionistas

7

Parte 2 · O preço e o momento de entrar

Esta parte não serve para saber se a empresa vale: serve para escolher quando comprá-la, depois que os fundamentos te convenceram. Dentro: análise técnica, potencial, quedas históricas, exposição gama.

Latest News

Recent headlines for CRVL, sourced from Markets Gazette.

No recent news for CRVL.